Dreherstr. 2/3 in Rastatt
07222 | 318 49

Publikationen

Startseite
Die Praxis
Unter­suchungs- und Behand­lungs­spektrum
Ihr erster Besuch

Publikations­verzeichnis

  1. Muller-Tasch T, Lowe B, Frankenstein L, Frey N, Haass M, Friederich HC. Somatic symptom profile in patients with chronic heart failure with and without depressive comorbidity. Front Psychiatry. 2024;15:1356497. doi: 10.3389/fpsyt.2024.1356497
  2. Heer T, Zeymer U, Hochadel M, Frankenstein L, Pauschinger M, Hambrecht R, Bruder O, Bohm M, Maier LS, Zahn R, et al. Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clinical research in cardiology : official journal of the German Cardiac Society. 2024. doi: 10.1007/s00392-024-02455-w
  3. Fröhlich H, Bossmeyer A, Kazmi S, Goode KM, Agewall S, Atar D, Grundtvig M, Frey N, Cleland JGF, Frankenstein L, Täger T. Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus. Clinical research in cardiology : official journal of the German Cardiac Society. 2024;113:822-830. doi: 10.1007/s00392-023-02268-3
  4. Zamorano JL, Appleby C, Benamer H, Frankenstein L, Musumeci G, Nombela-Franco L. Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement. Catheter Cardiovasc Interv. 2023. doi: 10.1002/ccd.30760
  5. Täger T, Rossmann P, Frey N, Estler B, Mack M, Schlegel P, Beckendorf J, Frankenstein L, Fröhlich H. Long-term trajectories of biomarkers, functional, and echocardiographic parameters in patients with chronic heart failure from dilated or ischaemic cardiomyopathy. Cardiology. 2023. doi: 10.1159/000532070
  6. Täger T, Franke J, Frey N, Frankenstein L, Fröhlich H. Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failure. Nutr Metab Cardiovasc Dis. 2023;33:416-423. doi: 10.1016/j.numecd.2022.10.017
  7. Neuendorff NR, Boshikova B, Frankenstein L, Kirchner M, Rohde C, Goldschmidt H, Frey N, Muller-Tidow C, Jordan K, Sauer S, et al. Aspirin use and bleeding events during thrombocytopenia after autologous stem-cell transplantation for multiple myeloma. Front Oncol. 2023;13:1168120. doi: 10.3389/fonc.2023.1168120
  8. Kuck KH, Leidl R, Frankenstein L, Wahlers T, Sarmah A, Candolfi P, Shore J, Green M. Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk. Adv Ther. 2023;40:1031-1046. doi: 10.1007/s12325-022-02392-y
  9. Fröhlich H, Bossmeyer A, Kazmi S, Goode KM, Agewall S, Atar D, Grundtvig M, Frey N, Cleland JGF, Frankenstein L, et al. Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus. Clinical research in cardiology : official journal of the German Cardiac Society. 2023. doi: 10.1007/s00392-023-02268-3
  10. Täger T, Frankenstein L, Atar D, Agewall S, Frey N, Grundtvig M, Clark AL, Cleland JGF, Fröhlich H. Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis. Clinical research in cardiology : official journal of the German Cardiac Society. 2022;111:428-439. doi: 10.1007/s00392-021-01913-z
  11. Täger T, Franke J, Frey N, Frankenstein L, Fröhlich H. Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failure. Nutr Metab Cardiovasc Dis. 2022. doi: 10.1016/j.numecd.2022.10.017
  12. Fröhlich H, Frey N, Frankenstein L, Täger T. The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies? Cardiology. 2022;147:529-538. doi: 10.1159/000527332
  13. Fröhlich H, Frey N, Estler B, Mack M, Schlegel P, Beckendorf J, Frankenstein L, Täger T. Haemodynamic Effects of Sacubitril/Valsartan Initiation in Outpatients with Chronic Heart Failure. Am J Cardiovasc Drugs. 2022;22:695-704. doi: 10.1007/s40256-022-00549-2
  14. Biener M, Giannitsis E, Hogrefe K, Mueller-Hennessen M, Fröhlich H, Katus HA, Frey N, Frankenstein L, Täger T. Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study. Clinical research in cardiology : official journal of the German Cardiac Society. 2022;111:333-342. doi: 10.1007/s00392-021-01952-6
  15. Täger T, Atar D, Agewall S, Katus HA, Grundtvig M, Cleland JGF, Clark AL, Fröhlich H, Frankenstein L. Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Fail Rev. 2021;26:1421-1435. doi: 10.1007/s10741-020-09954-8
  16. Mathy RM, Kuhn TC, Kappes J, Wielputz MO, Ruhparwar A, Frankenstein L, Tanner M, Geis N, Fischer C, Kasperk C, et al. Intracardial PMMA bone cement embolism after kyphoplasty-an unusual cause for sudden chest pain, hemothorax and hemopericardium. Med Klin Intensivmed Notfmed. 2021;116:61-64. doi: 10.1007/s00063-020-00698-9
  17. Frankenstein L, Kaier K, Katus HA, Bode C, Wengenmayer T, von Zur Muhlen C, Bekeredjian R, Täger T, Zehender M, Fröhlich H, et al. Impact of the introduction of percutaneous edge-to-edge mitral valve reconstruction on clinical practice in Germany compared to surgical valve repair. Clinical research in cardiology : official journal of the German Cardiac Society. 2021;110:620-627. doi: 10.1007/s00392-020-01675-0
  18. Täger T, Atar D, Agewall S, Katus HA, Grundtvig M, Cleland JGF, Clark AL, Fröhlich H, Frankenstein L. Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Fail Rev. 2020. doi: 10.1007/s10741-020-09954-8
  19. Shore J, Russell J, Frankenstein L, Candolfi P, Green M. An analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UK. J Med Econ. 2020:1-20. doi: 10.1080/13696998.2020.1854769
  20. Sedaghat-Hamedani F, Kayvanpour E, Hamed S, Frankenstein L, Riffel J, Gi WT, Amr A, Shirvani Samani O, Haas J, Miersch T, et al. The chameleon of cardiology: cardiac sarcoidosis before and after heart transplantation. ESC Heart Fail. 2020;7:692-696. doi: 10.1002/ehf2.12581
  21. Meindl C, Hochadel M, Frankenstein L, Bruder O, Pauschinger M, Hambrecht R, von Scheidt W, Pfister O, Hartmann A, Maier LS, et al. The role of diabetes in cardiomyopathies of different etiologies-Characteristics and 1-year follow-up results of the EVITA-HF registry. PLoS One. 2020;15:e0234260. doi: 10.1371/journal.pone.0234260
  22. Lossnitzer N, Feisst M, Wild B, Katus HA, Schultz JH, Frankenstein L, Stock C. Cross-lagged analyses of the bidirectional relationship between depression and markers of chronic heart failure. Depress Anxiety. 2020;37:898-907. doi: 10.1002/da.23041
  23. Jilek C, Lewalter T, Pauschinger M, von Scheidt W, Frankenstein L, Pfister O, Hambrecht R, Bruder O, Brachmann J, Hartmann A, et al. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction. Clinical research in cardiology : official journal of the German Cardiac Society. 2020;109:115-123. doi: 10.1007/s00392-019-01503-0
  24. Grossekettler L, Schmack B, Brockmann C, Wanninger R, Kreusser MM, Frankenstein L, Kihm LP, Zeier M, Katus HA, Schwenger V, et al. Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients. BMC Nephrol. 2020;21:179. doi: 10.1186/s12882-020-01777-x
  25. Geis N, Raake P, Kiriakou C, Mereles D, Frankenstein L, Abu-Sharar H, Chorianopoulos E, Katus HA, Bekeredjian R, Pleger ST. Temporary oral anticoagulation after MitraClip - a strategy to lower the incidence of post-procedural stroke? Acta Cardiol. 2020;75:61-67. doi: 10.1080/00015385.2018.1550886
  26. Frankenstein L, Seide S, Täger T, Jensen K, Fröhlich H, Clark AL, Seiz M, Katus HA, Nee P, Uhlmann L, et al. Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials. Heart Fail Rev. 2020;25:161-171. doi: 10.1007/s10741-019-09832-y
  27. Frankenstein L, Kaier K, Katus HA, Bode C, Wengenmayer T, von Zur Muhlen C, Bekeredjian R, Täger T, Zehender M, Fröhlich H, et al. Impact of the introduction of percutaneous edge-to-edge mitral valve reconstruction on clinical practice in Germany compared to surgical valve repair. Clinical research in cardiology : official journal of the German Cardiac Society. 2020. doi: 10.1007/s00392-020-01675-0
  28. Täger T, Giannitsis E, Greve K, Fröhlich H, Muller-Hennessen M, Vafaie M, Katus HA, Frankenstein L, Biener M. Long-term biological variation of high-sensitivity cardiac troponin T using minimal important differences and reference change values in stable outpatients with cardiovascular disease. Clin Biochem. 2019;67:7-11. doi: 10.1016/j.clinbiochem.2019.03.003
  29. Täger T, Fröhlich H, Seiz M, Katus HA, Frankenstein L. READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials. Heart Fail Rev. 2019;24:461-472. doi: 10.1007/s10741-019-09771-8
  30. Täger T, Fröhlich H, Grundtvig M, Seiz M, Schellberg D, Goode K, Kazmi S, Hole T, Katus HA, Atar D, et al. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis. International journal of cardiology. 2019;289:83-90. doi: 10.1016/j.ijcard.2019.01.109
  31. Sedaghat-Hamedani F, Kayvanpour E, Hamed S, Frankenstein L, Riffel J, Gi WT, Amr A, Shirvani Samani O, Haas J, Miersch T, et al. The chameleon of cardiology: cardiac sarcoidosis before and after heart transplantation. ESC Heart Fail. 2019. doi: 10.1002/ehf2.12581
  32. Schnorbach J, Fröhlich H, Täger T, Corletto A, Katus HA, Frankenstein L. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure. ESC Heart Fail. 2019;6:640-648. doi: 10.1002/ehf2.12464
  33. Kreuter M, Lederer DJ, Molina-Molina M, Noth I, Valenzuela C, Frankenstein L, Weycker D, Atwood M, Kirchgaessler KU, Cottin V. Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis. Chest. 2019;156:706-714. doi: 10.1016/j.chest.2019.04.015
  34. Grossekettler L, Schmack B, Meyer K, Brockmann C, Wanninger R, Kreusser MM, Frankenstein L, Kihm LP, Zeier M, Katus HA, et al. Peritoneal dialysis as therapeutic option in heart failure patients. ESC Heart Fail. 2019;6:271-279. doi: 10.1002/ehf2.12411
  35. Geis N, Raake P, Kiriakou C, Mereles D, Frankenstein L, Abu-Sharar H, Chorianopoulos E, Katus HA, Bekeredjian R, Pleger ST. Temporary oral anticoagulation after MitraClip - a strategy to lower the incidence of post-procedural stroke? Acta Cardiol. 2019:1-7. doi: 10.1080/00015385.2018.1550886
  36. Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, et al. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe. Heart. 2019;105:1252-1259. doi: 10.1136/heartjnl-2018-314256
  37. Frankenstein L, Seide S, Täger T, Jensen K, Fröhlich H, Clark AL, Seiz M, Katus HA, Nee P, Uhlmann L, et al. Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials. Heart Fail Rev. 2019. doi: 10.1007/s10741-019-09832-y
  38. Zelniker TA, Huscher D, Vonk-Noordegraaf A, Ewert R, Lange TJ, Klose H, Dumitrescu D, Halank M, Held M, Gall H, et al. The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry. Clinical research in cardiology : official journal of the German Cardiac Society. 2018;107:460-470. doi: 10.1007/s00392-018-1207-5
  39. Reinhold T, Giannitsis E, Mockel M, Frankenstein L, Vafaie M, Vollert JO, Slagman A. Cost analysis of early discharge using combined copeptin/cardiac troponin testing versus serial cardiac troponin testing in patients with suspected acute coronary syndrome. PLoS One. 2018;13:e0202133. doi: 10.1371/journal.pone.0202133
  40. Muller-Tasch T, Lowe B, Lossnitzer N, Frankenstein L, Täger T, Haass M, Katus H, Schultz JH, Herzog W. Anxiety and self-care behaviour in patients with chronic systolic heart failure: A multivariate model. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology. 2018;17:170-177. doi: 10.1177/1474515117722255
  41. Kristen AV, Kreusser MM, Blum P, Schonland SO, Frankenstein L, Dosch AO, Knop B, Helmschrott M, Schmack B, Ruhparwar A, et al. Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018;37:611-618. doi: 10.1016/j.healun.2017.11.015
  42. Kreusser MM, Tschierschke R, Beckendorf J, Baxmann T, Frankenstein L, Dosch AO, Schultz JH, Giannitsis E, Pleger ST, Ruhparwar A, et al. The need for dedicated advanced heart failure units to optimize heart failure care: impact of optimized advanced heart failure unit care on heart transplant outcome in high-risk patients. ESC Heart Fail. 2018. doi: 10.1002/ehf2.12314
  43. Kaier K, Reinecke H, Naci H, Frankenstein L, Bode M, Vach W, Hehn P, Zirlik A, Zehender M, Reinohl J. The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany. Eur J Health Econ. 2018;19:223-228. doi: 10.1007/s10198-017-0877-7
  44. Kaier K, Oettinger V, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, von Zur Muhlen C, Bode C, Zehender M, et al. Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health records. BMJ Open. 2018;8:e020204. doi: 10.1136/bmjopen-2017-020204
  45. Geis NA, Pleger ST, Bekeredjian R, Chorianopoulos E, Kreusser MM, Frankenstein L, Ruhparwar A, Katus HA, Raake PWJ. Haemodynamic effects of percutaneous mitral valve edge-to-edge repair in patients with end-stage heart failure awaiting heart transplantation. ESC Heart Fail. 2018. doi: 10.1002/ehf2.12313
  46. Geis N, Raake P, Lewening M, Mereles D, Chorianopoulos E, Frankenstein L, Katus HA, Bekeredjian R, Pleger ST. Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment. Acta Cardiol. 2018;73:378-386. doi: 10.1080/00015385.2017.1401275
  47. Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, et al. Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study. Eur Heart J Cardiovasc Pharmacother. 2018;4:82-92. doi: 10.1093/ehjcvp/pvx013
  48. Corletto A, Fröhlich H, Täger T, Hochadel M, Zahn R, Kilkowski C, Winkler R, Senges J, Katus HA, Frankenstein L. Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy. Clinical research in cardiology : official journal of the German Cardiac Society. 2018. doi: 10.1007/s00392-018-1277-4
  49. Aurich M, Fuchs P, Muller-Hennessen M, Uhlmann L, Niemers M, Greiner S, Täger T, Hirschberg K, Ehlermann P, Meder B, et al. Unidimensional Longitudinal Strain: A Simple Approach for the Assessment of Longitudinal Myocardial Deformation by Echocardiography. J Am Soc Echocardiogr. 2018. doi: 10.1016/j.echo.2017.12.010
  50. Ambavane A, Lindahl B, Giannitsis E, Roiz J, Mendivil J, Frankenstein L, Body R, Christ M, Bingisser R, Alquezar A, et al. Correction: Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department. PLoS One. 2018;13:e0191348. doi: 10.1371/journal.pone.0191348
  51. Uszko-Lencer N, Frankenstein L, Spruit MA, Maeder MT, Gutmann M, Muzzarelli S, Osswald S, Pfisterer ME, Zugck C, Brunner-La Rocca HP, et al. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index. International journal of cardiology. 2017;227:901-907. doi: 10.1016/j.ijcard.2016.11.122
  52. Täger T, Wiedergruen AK, Fröhlich H, Cebola R, Corletto A, Horsch A, Hess G, Slottje K, Zdunek D, Katus HA, et al. Hemodynamic Determinants of the Biologic Variation of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Stable Systolic Chronic Heart Failure. J Card Fail. 2017;23:835-842. doi: 10.1016/j.cardfail.2017.07.404
  53. Täger T, Wiebalck C, Fröhlich H, Corletto A, Katus HA, Frankenstein L. Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure. Clinical research in cardiology : official journal of the German Cardiac Society. 2017;106:974-985. doi: 10.1007/s00392-017-1147-5
  54. Muller-Tasch T, Lowe B, Lossnitzer N, Frankenstein L, Täger T, Haass M, Katus H, Schultz JH, Herzog W. Anxiety and self-care behaviour in patients with chronic systolic heart failure: A multivariate model. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology. 2017:1474515117722255. doi: 10.1177/1474515117722255
  55. Malyar NM, Kaier K, Freisinger E, Luders F, Kaleschke G, Baumgartner H, Frankenstein L, Reinecke H, Reinohl J. Prevalence and impact of critical limb ischaemia on in-hospital outcome in transcatheter aortic valve implantation in Germany. EuroIntervention. 2017;13:1281-1287. doi: 10.4244/EIJ-D-17-00228
  56. Kristen AV, Kreusser MM, Blum P, Schonland SO, Frankenstein L, Dosch AO, Knop B, Helmschrott M, Schmack B, Ruhparwar A, et al. Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2017. doi: 10.1016/j.healun.2017.11.015
  57. Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, Zirlik A, Bode C, Zehender M, Reinohl J. Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study. International journal of cardiology. 2017;235:17-21. doi: 10.1016/j.ijcard.2017.02.138
  58. Kaier K, Reinecke H, Naci H, Frankenstein L, Bode M, Vach W, Hehn P, Zirlik A, Zehender M, Reinohl J. The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany. Eur J Health Econ. 2017. doi: 10.1007/s10198-017-0877-7
  59. Gutmann A, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Bothe W, von Zur Muhlen C, Zehender M, Reinohl J, Bode C, et al. Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement. EuroIntervention. 2017;13:804-810. doi: 10.4244/EIJ-D-16-00927
  60. Geis N, Raake P, Lewening M, Mereles D, Chorianopoulos E, Frankenstein L, Katus HA, Bekeredjian R, Pleger ST. Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment. Acta Cardiol. 2017:1-9. doi: 10.1080/00015385.2017.1401275
  61. Gastelurrutia P, Lupon J, Domingo M, Stut W, Dovancescu S, Cleland J, Frankenstein L, Bayes-Genis A, HeartCycle Programme I. Potential role for clinical calibration to increase engagement with and application of home telemonitoring: a report from the HeartCycle programme. ESC Heart Fail. 2017;4:66-70. doi: 10.1002/ehf2.12104
  62. Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, et al. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clinical research in cardiology : official journal of the German Cardiac Society. 2017;106:711-721. doi: 10.1007/s00392-017-1115-0
  63. Fröhlich H, Raman N, Täger T, Schellberg D, Goode KM, Kazmi S, Grundtvig M, Hole T, Cleland JGF, Katus HA, et al. Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure. International journal of cardiology. 2017;238:97-104. doi: 10.1016/j.ijcard.2017.03.028
  64. Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, et al. Comparative effectiveness of enalapril, lisinopril and ramipril in the treatment of patients with chronic heart failure. A propensity score matched cohort study. Eur Heart J Cardiovasc Pharmacother. 2017. doi: 10.1093/ehjcvp/pvx013
  65. Ambavane A, Lindahl B, Giannitis E, Roiz J, Mendivil J, Frankenstein L, Body R, Christ M, Bingisser R, Alquezar A, et al. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department. PLoS One. 2017;12:e0187662. doi: 10.1371/journal.pone.0187662
  66. Rizos T, Horstmann S, Dittgen F, Täger T, Jenetzky E, Heuschmann P, Veltkamp R. Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke. Stroke. 2016;47:336-341. doi: 10.1161/STROKEAHA.115.011465
  67. Rivinius R, Helmschrott M, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Darche FF, Schweizer PA, et al. Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation. Drug design, development and therapy. 2016;10:677-686. doi: 10.2147/DDDT.S96126
  68. Riffel JH, Keller MG, Rost F, Arenja N, Andre F, Aus dem Siepen F, Fritz T, Ehlermann P, Täger T, Frankenstein L, et al. Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy? J Cardiovasc Magn Reson. 2016;18:36. doi: 10.1186/s12968-016-0255-0
  69. Reinohl J, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Zehender M, von Zur Muhlen C, Bode C, Stachon P. Transcatheter Aortic Valve Replacement: The New Standard in Patients With Previous Coronary Bypass Grafting? JACC Cardiovasc Interv. 2016;9:2137-2143. doi: 10.1016/j.jcin.2016.07.035
  70. Fröhlich H, Nelges C, Täger T, Schwenger V, Cebola R, Schnorbach J, Goode KM, Kazmi S, Katus HA, Cleland JG, et al. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease. Am Heart J. 2016;178:28-36. doi: 10.1016/j.ahj.2016.03.024
  71. Fröhlich H, Herrmann K, Franke J, Karimi A, Täger T, Cebola R, Katus HA, Zugck C, Frankenstein L. Periodontitis in Chronic Heart Failure. Tex Heart Inst J. 2016;43:297-304. doi: 10.14503/THIJ-15-5200
  72. Franke J, Keppler J, Abadei AK, Bajrovic A, Meme L, Zugck C, Raake PW, Zitron E, Katus HA, Frankenstein L. Long-term outcome of patients with and without super-response to CRT-D. Clinical research in cardiology : official journal of the German Cardiac Society. 2016;105:341-348. doi: 10.1007/s00392-015-0926-0
  73. Täger T, Schell M, Cebola R, Fröhlich H, Dosch A, Franke J, Katus HA, Wians FH, Jr., Frankenstein L. Biological variation, reference change value (RCV) and minimal important difference (MID) of inspiratory muscle strength (PImax) in patients with stable chronic heart failure. Clinical research in cardiology : official journal of the German Cardiac Society. 2015;104:822-830. doi: 10.1007/s00392-015-0850-3
  74. äger T, Fröhlich H, Franke J, Slottje K, Horsch A, Zdunek D, Hess G, Dosch A, Katus HA, Wians FH, et al. Biological variation of the cardiac index in patients with stable chronic heart failure: inert gas rebreathing compared with impedance cardiography. ESC Heart Fail. 2015;2:112-120. doi: 10.1002/ehf2.12040
  75. Sedaghat-Hamedani F, Kayvanpour E, Frankenstein L, Mereles D, Amr A, Buss S, Keller A, Giannitsis E, Jensen K, Katus HA, et al. Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury--a metaanalysis of 45 studies. Clinical chemistry. 2015;61:1246-1255. doi: 10.1373/clinchem.2015.240796
  76. Rivinius R, Helmschrott M, Ruhparwar A, Schmack B, Klein B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Darche FF, et al. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. Drug design, development and therapy. 2015;9:93-102. doi: 10.2147/DDDT.S75464
  77. Reinohl J, Kaier K, Reinecke H, Schmoor C, Frankenstein L, Vach W, Cribier A, Beyersdorf F, Bode C, Zehender M. Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice. N Engl J Med. 2015;373:2438-2447. doi: 10.1056/NEJMoa1500893
  78. Lossnitzer N, Herzog W, Schultz JH, Täger T, Frankenstein L, Wild B. A patient-centered perspective of treating depressive symptoms in chronic heart failure: What do patients prefer? Patient education and counseling. 2015;98:783-787. doi: 10.1016/j.pec.2015.02.008
  79. Helmschrott M, Rivinius R, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Frankenstein L, Ehlermann P, Bruckner T, et al. Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation. Drug design, development and therapy. 2015;9:1217-1224. doi: 10.2147/DDDT.S79343
  80. Fröhlich H, Zhao J, Täger T, Cebola R, Schellberg D, Katus HA, Grundtvig M, Hole T, Atar D, Agewall S, et al. Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study. Circulation Heart failure. 2015;8:887-896. doi: 10.1161/CIRCHEARTFAILURE.114.001701
  81. Fröhlich H, Katus HA, Täger T, Lossnitzer N, Grossekettler L, Kihm L, Zeier M, Remppis A, Frankenstein L, Schwenger V. Peritoneal ultrafiltration in end-stage chronic heart failure. Clinical kidney journal. 2015;8:219-225. doi: 10.1093/ckj/sfv007
  82. Frankenstein L, Fröhlich H, Cleland JG. Multidisciplinary Approach for Patients Hospitalized With Heart Failure. Rev Esp Cardiol (Engl Ed). 2015;68:885-891. doi: 10.1016/j.rec.2015.05.008
  83. Franke J, Zugck C, Hochadel M, Hack A, Frankenstein L, Zhao JD, Ehlermann P, Nelles M, Zeymer U, Winkler R, et al. Etiology-specific assessment of predictors of long-term survival in chronic systolic heart failure. Int J Cardiol Heart Vasc. 2015;7:61-68. doi: 10.1016/j.ijcha.2015.01.015
  84. Franke J, Lindmark A, Hochadel M, Zugck C, Koerner E, Keppler J, Ehlermann P, Winkler R, Zahn R, Katus HA, et al. Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score. Clinical research in cardiology : official journal of the German Cardiac Society. 2015;104:334-341. doi: 10.1007/s00392-014-0786-z
  85. Franke J, Keppler J, Abadei AK, Bajrovic A, Meme L, Zugck C, Raake PW, Zitron E, Katus HA, Frankenstein L. Long-term outcome of patients with and without super-response to CRT-D. Clinical research in cardiology : official journal of the German Cardiac Society. 2015. doi: 10.1007/s00392-015-0926-0
  86. Buss SJ, Breuninger K, Lehrke S, Voss A, Galuschky C, Lossnitzer D, Andre F, Ehlermann P, Franke J, Täger T, et al. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy. European heart journal cardiovascular Imaging. 2015;16:307-315. doi: 10.1093/ehjci/jeu181
  87. Täger T, Hanholz W, Cebola R, Fröhlich H, Franke J, Doesch A, Katus HA, Wians FH, Jr., Frankenstein L. Minimal important difference for 6-minute walk test distances among patients with chronic heart failure. International journal of cardiology. 2014;176:94-98. doi: 10.1016/j.ijcard.2014.06.035
  88. Lossnitzer N, Wild B, Schultz JH, Frankenstein L, Haass M, Rauch B, Lowe B, Katus H, Herzog W. Potentially modifiable correlates of functional status in patients with chronic heart failure. International journal of behavioral medicine. 2014;21:956-960. doi: 10.1007/s12529-014-9385-7
  89. Lossnitzer N, Wagner E, Wild B, Frankenstein L, Rosendahl J, Leppert K, Herzog W, Schultz JH. [Resilience in chronic heart failure]. Deutsche medizinische Wochenschrift. 2014;139:580-584. doi: 10.1055/s-0034-1369862
  90. Franke J, Lindmark A, Hochadel M, Zugck C, Koerner E, Keppler J, Ehlermann P, Winkler R, Zahn R, Katus HA, et al. Gender aspects in clinical presentation and prognostication of chronic heart failure according to NT-proBNP and the Heart Failure Survival Score. Clinical research in cardiology : official journal of the German Cardiac Society. 2014. doi: 10.1007/s00392-014-0786-z
  91. Peters-Klimm F, Freund T, Kunz CU, Laux G, Frankenstein L, Muller-Tasch T, Szecsenyi J. Determinants of heart failure self-care behaviour in community-based patients: a cross-sectional study. European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology. 2013;12:167-176. doi: 10.1177/1474515112439964
  92. Kraeuter M, Helmschrott M, Erbel C, Gleissner CA, Frankenstein L, Schmack B, Ruhparwar A, Ehlermann P, Katus HA, Doesch AO. Conversion to generic cyclosporine A in stable chronic patients after heart transplantation. Drug design, development and therapy. 2013;7:1421-1426. doi: 10.2147/DDDT.S54245
  93. Gueler I, Mueller S, Helmschrott M, Oeing CU, Erbel C, Frankenstein L, Gleissner C, Ruhparwar A, Ehlermann P, Dengler TJ, et al. Effects of vildagliptin (Galvus(R)) therapy in patients with type 2 diabetes mellitus after heart transplantation. Drug design, development and therapy. 2013;7:297-303. doi: 10.2147/DDDT.S43092
  94. Frankenstein L, Katus HA, Grundtvig M, Hole T, de Blois J, Schellberg D, Atar D, Zugck C, Agewall S, Norwegian Heart Failure Registry steering c. Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study. European journal of clinical pharmacology. 2013;69:1747-1755. doi: 10.1007/s00228-013-1512-x
  95. Frankenstein L, Hees H, Täger T, Fröhlich H, Dosch A, Cebola R, Zugck C, Katus HA. Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy. Clinical research in cardiology : official journal of the German Cardiac Society. 2013;102:771-780. doi: 10.1007/s00392-013-0589-7
  96. Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA. Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study. Drug design, development and therapy. 2013;7:1323-1328. doi: 10.2147/DDDT.S53705
  97. Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug design, development and therapy. 2013;7:1253-1258. doi: 10.2147/DDDT.S52820
  98. Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, et al. Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clinical research in cardiology : official journal of the German Cardiac Society. 2012;101:263-272. doi: 10.1007/s00392-011-0388-y
  99. Frankenstein L, Clark AL, Ribeiro JP. Influence of sex on treatment and outcome in chronic heart failure. Cardiovascular therapeutics. 2012;30:182-192. doi: 10.1111/j.1755-5922.2010.00253.x
  100. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, et al. A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clinical research in cardiology : official journal of the German Cardiac Society. 2012;101:1-10. doi: 10.1007/s00392-011-0348-6
  101. Doesch AO, Repp J, Hofmann N, Erbel C, Frankenstein L, Gleissner CA, Schmidt C, Ruhparwar A, Zugck C, Schnitzler P, et al. Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients. Drug design, development and therapy. 2012;6:289-295. doi: 10.2147/DDDT.S36578
  102. Frankenstein L, Wu AH, Hallermayer K, Wians FH, Jr., Giannitsis E, Katus HA. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clinical chemistry. 2011;57:1068-1071. doi: 10.1373/clinchem.2010.158964
  103. Frankenstein L, Remppis A, Giannitis E, Frankenstein J, Hess G, Zdunek D, Doesch A, Zugck C, Katus HA. Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy. Clinical research in cardiology : official journal of the German Cardiac Society. 2011;100:633-640. doi: 10.1007/s00392-011-0285-4
  104. Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M, Katus HA, Clark AL, Cleland JG, Zugck C. Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status--do we need specificity for sex and beta-blockers? International journal of cardiology. 2011;147:74-78. doi: 10.1016/j.ijcard.2009.08.005
  105. Frankenstein L. The difficult task of finding the best antihypertensive agent: comment on "antihypertensive treatment and development of heart failure in hypertension". Archives of internal medicine. 2011;171:394-395. doi: 10.1001/archinternmed.2010.414
  106. Franke J, Frankenstein L, Schellberg D, Bajrovic A, Wolter JS, Ehlermann P, Doesch AO, Nelles M, Katus HA, Zugck C. Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? Clinical research in cardiology : official journal of the German Cardiac Society. 2011;100:1059-1067. doi: 10.1007/s00392-011-0340-1
  107. Doesch AO, Mueller S, Nelles M, Konstandin M, Celik S, Frankenstein L, Goeser S, Kaya Z, Koch A, Zugck C, et al. Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy. Basic research in cardiology. 2011;106:25-35. doi: 10.1007/s00395-010-0126-z
  108. Reutlinger J, Muller-Tasch T, Schellberg D, Frankenstein L, Zugck C, Herzog W, Lossnitzer N. [Depression, social support and compliance in patients with chronic heart failure]. Psychotherapie, Psychosomatik, medizinische Psychologie. 2010;60:380-384. doi: 10.1055/s-0030-1254146
  109. Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, Zugck C. The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. European journal of heart failure. 2010;12:574-580. doi: 10.1093/eurjhf/hfq047
  110. Ferreira AM, Tabet JY, Frankenstein L, Metra M, Mendes M, Zugck C, Beauvais F, Cohen-Solal A. Ventilatory efficiency and the selection of patients for heart transplantation. Circulation Heart failure. 2010;3:378-386. doi: 10.1161/CIRCHEARTFAILURE.108.847392
  111. Doesch AO, Muller S, Konstandin M, Celik S, Kristen A, Frankenstein L, Ehlermann P, Sack FU, Katus HA, Dengler TJ. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. Transplantation proceedings. 2010;42:3694-3699. doi: 10.1016/j.transproceed.2010.07.107
  112. Doesch AO, Mueller S, Konstandin M, Celik S, Kristen A, Frankenstein L, Goeser S, Kaya Z, Zugck C, Dengler TJ, et al. Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy. Journal of clinical apheresis. 2010;25:315-322. doi: 10.1002/jca.20263
  113. Doesch AO, Mueller S, Konstandin M, Celik S, Erbel C, Kristen A, Frankenstein L, Koch A, Ehlermann P, Zugck C, et al. Proton pump inhibitor co-medication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil. Transplantation proceedings. 2010;42:4243-4246. doi: 10.1016/j.transproceed.2010.09.047
  114. Doesch AO, Mueller S, Konstandin M, Celik S, Erbel C, Kristen A, Frankenstein L, Koch A, Dengler TJ, Ehlermann P, et al. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Transplantation proceedings. 2010;42:4238-4242. doi: 10.1016/j.transproceed.2010.09.074
  115. Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Muller S, Sack FU, Katus HA, Dengler TJ. Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation. Transplant international : official journal of the European Society for Organ Transplantation. 2010;23:382-389. doi: 10.1111/j.1432-2277.2009.00993.x
  116. Ribeiro JP, Chiappa GR, Neder JA, Frankenstein L. Respiratory muscle function and exercise intolerance in heart failure. Current heart failure reports. 2009;6:95-101.
  117. Frankenstein L, Zugck C, Schellberg D, Nelles M, Fröhlich H, Katus H, Remppis A. Prevalence and prognostic significance of adrenergic escape during chronic beta-blocker therapy in chronic heart failure. European journal of heart failure. 2009;11:178-184. doi: 10.1093/eurjhf/hfn028
  118. Frankenstein L, Zugck C, Nelles M, Schellberg D, Katus HA, Remppis BA. The obesity paradox in stable chronic heart failure does not persist after matching for indicators of disease severity and confounders. European journal of heart failure. 2009;11:1189-1194. doi: 10.1093/eurjhf/hfp150
  119. Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Slottje K, Katus HA, Zugck C. Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables. Clinical chemistry. 2009;55:923-929. doi: 10.1373/clinchem.2008.112052
  120. Frankenstein L, Remppis A, Frankenstein J, Hess G, Zdunek D, Gut S, Slottje K, Katus HA, Zugck C. Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure. Basic research in cardiology. 2009;104:731-738. doi: 10.1007/s00395-009-0027-1
  121. Frankenstein L, Nelles M, Meyer FJ, Sigg C, Schellberg D, Remppis BA, Katus HA, Zugck C. Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2009;16:424-429. doi: 10.1097/HJR.0b013e3283030a7e
  122. Frankenstein L, Clark AL, Goode K, Ingle L, Remppis A, Schellberg D, Grabs F, Nelles M, Cleland JG, Katus HA, et al. The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart. 2009;95:825-829. doi: 10.1136/hrt.2008.158626
  123. Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Hardt S, Goeser S, Kaya Z, Katus HA, Dengler TJ. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy. Journal of clinical apheresis. 2009;24:141-149. doi: 10.1002/jca.20204
  124. Zugck C, Remppis A, Katus HA, Frankenstein L. [Chronic systolic heart failure - dosing recommendations at beginning and end of treatment]. Therapeutische Umschau Revue therapeutique. 2008;65:585-592. doi: 10.1024/0040-5930.65.10.585
  125. Muller-Tasch T, Frankenstein L, Holzapfel N, Schellberg D, Lowe B, Nelles M, Zugck C, Katus H, Rauch B, Haass M, et al. Panic disorder in patients with chronic heart failure. Journal of psychosomatic research. 2008;64:299-303. doi: 10.1016/j.jpsychores.2007.09.002
  126. Frankenstein L, Zugck C, Nelles M, Schellberg D, Remppis A, Katus H. Primary ICD-therapy in patients with advanced heart failure: selection strategies and future trials. Clinical research in cardiology : official journal of the German Cardiac Society. 2008;97:594-600. doi: 10.1007/s00392-008-0656-7
  127. Frankenstein L, Zugck C, Nelles M, Schellberg D, Katus H, Remppis A. Sex-specific predictive power of 6-minute walk test in chronic heart failure is not enhanced using percent achieved of published reference equations. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2008;27:427-434. doi: 10.1016/j.healun.2008.01.010
  128. Frankenstein L, Remppis A, Nelles M, Schaelling B, Schellberg D, Katus H, Zugck C. Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status. European heart journal. 2008;29:2634-2640. doi: 10.1093/eurheartj/ehn388
  129. Frankenstein L, Remppis A, Graham J, Schellberg D, Sigg C, Nelles M, Katus HA, Zugck C. Gender and age related predictive value of walk test in heart failure: do anthropometrics matter in clinical practice? International journal of cardiology. 2008;127:331-336. doi: 10.1016/j.ijcard.2007.04.087
  130. Frankenstein L, Meyer FJ, Sigg C, Nelles M, Schellberg D, Remppis A, Katus HA, Zugck C. Is serial determination of inspiratory muscle strength a useful prognostic marker in chronic heart failure? European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 2008;15:156-161. doi: 10.1097/HJR.0b013e3282f0d6ea
  131. Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients. Transplant international : official journal of the European Society for Organ Transplantation. 2008;21:963-971. doi: 10.1111/j.1432-2277.2008.00709.x
  132. Frankenstein L, Nelles M, Slavutsky M, Schellberg D, Doesch A, Katus H, Remppis A, Zugck C. Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007;26:1033-1039. doi: 10.1016/j.healun.2007.07.030
  133. Frankenstein L, Nelles M, Hallerbach M, Dukic D, Fluegel A, Schellberg D, Katus HA, Remppis A, Zugck C. Prognostic impact of peakVO2-changes in stable CHF on chronic beta-blocker treatment. International journal of cardiology. 2007;122:125-130. doi: 10.1016/j.ijcard.2006.11.038
  134. Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine. Transplantation. 2007;84:988-996. doi: 10.1097/01.tp.0000285265.86954.80
  135. Zugck C, Nelles M, Frankenstein L, Schultz C, Helms T, Korb H, Katus HA, Remppis A. [Telemonitoring in chronic heart failure patients. Which diagnostic finding prevents hospital readmission?]. Herzschrittmachertherapie & Elektrophysiologie. 2005;16:176-182. doi: 10.1007/s00399-005-0476-7
  136. Leder U, Saul T, Frankenstein L, Krack A, Baer H, Poehlmann G, Figulla HR. Exercise capacity and Doppler pressure measurements in symptomatic peripheral arterial obstructive disease. VASA Zeitschrift fur Gefasskrankheiten. 2002;31:107-110.
  137. Leder U, Haueisen J, Liehr M, Baier V, Frankenstein L, Nowak H, Figulla HR. High frequency intra-QRS signals in idiopathic dilated cardiomyopathy. Biomedizinische Technik Biomedical engineering. 2002;47:117-123.
  138. Leder U, Frankenstein L, Haas J, Baier V, Haueisen J, Nowak H, Figulla HR. Temporal properties of high frequency intra-QRS signals in myocardial infarction and healthy hearts. Biomedizinische Technik Biomedical engineering. 2000;45:243-247.

Kardiologie
in den Ankerarkaden

Gemeinschaftspraxis
Prof. Dr. Frankenstein
und Prof. Dr. Täger

Dreherstr. 2/3
76437 Rastatt

Anfahrt

T 07222 | 318 49
F 07222 | 931 6666
M praxis@kardiologie-rastatt.de

Öffnungszeiten

Mo 7:30 - 12:30 u. 14:00 - 18:00
Di 7:30 - 12:30 u. 14:00 - 18:00
Mi 7:30 - 12:30 u. 14:00 - 16:00
Do 7:30 - 12:30 u. 14:00 - 18:00
Fr 7:30 - 12:30 u. 14:00 - 16:00
und nach Vereinbarung

Im Notfall

T 112
T 116 117

Recht

Impressum
Datenschutz